본문 바로가기
KERD
논문KCI 등재

중증 천식과 기침

Cough in Severe Asthma

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류내과학

초록

Asthma is a heterogeneous clinical syndrome that presents with variable symptoms, including cough, breathlessness, chest discomfort, and wheezing. Cough, a primary symptom of asthma, has distinct regulatory mechanisms and was associated with asthma severity, poor asthma control, diminished quality of life, and an increased risk of frequent future exacerbations. However, current tools for measuring asthma control do not include separate items for cough or other specific symptoms, and the true impact and clinical relevance of cough in asthma remains poorly understood. Consequently, current stepwise treatment algorithms based on asthma control may be overly simplistic and might not adequately address the heterogeneity of asthma or the mechanisms underlying its symptoms. Furthermore, this approach carries the risk of overestimating asthma severity and subsequent overtreatment. The concept of treatable traits is fundamental to precision medicine, wherein each symptom, especially cough, may serve as a treatable trait in its own right. In this paper, we aim to present evidence supporting the concept of cough as a treatable trait in asthma, addressing its three major components, which are clinical relevance, measurability, and treatability.

Abstract

Asthma is a heterogeneous clinical syndrome that presents with variable symptoms, including cough, breathlessness, chest discomfort, and wheezing. Cough, a primary symptom of asthma, has distinct regulatory mechanisms and was associated with asthma severity, poor asthma control, diminished quality of life, and an increased risk of frequent future exacerbations. However, current tools for measuring asthma control do not include separate items for cough or other specific symptoms, and the true impact and clinical relevance of cough in asthma remains poorly understood. Consequently, current stepwise treatment algorithms based on asthma control may be overly simplistic and might not adequately address the heterogeneity of asthma or the mechanisms underlying its symptoms. Furthermore, this approach carries the risk of overestimating asthma severity and subsequent overtreatment. The concept of treatable traits is fundamental to precision medicine, wherein each symptom, especially cough, may serve as a treatable trait in its own right. In this paper, we aim to present evidence supporting the concept of cough as a treatable trait in asthma, addressing its three major components, which are clinical relevance, measurability, and treatability.

참고문헌 (51)

  1. Anderson GP, "Endotyping asthma : new insights into key pathogenic mechanisms in a complex, heterogeneous disease", Lancet, 372, pp.1107~1119 (2008)
  2. 박소영, "Evolving Concept of Severe Asthma: Transition From Diagnosis to Treatable Traits", Allergy, Asthma & Immunology Research, 14(5), pp.447~464 (2022), 대한천식알레르기학회[DOI]
  3. Tan DJ, "Age-of-asthma onset as a determinant of different asthma phenotypes in adults : a systematic review and meta-analysis of the literature", Expert Rev Respir Med, 9, pp.109~123 (2015)
  4. ten Brinke A, "Risk factors associated with irreversible airflow limitation in asthma", Curr Opin Allergy Clin Immunol, 8, pp.63~69 (2008)
  5. Song WJ, "Staphylococcal enterotoxin IgE sensitization in late-onset severe eosinophilic asthma in the elderly", Clin Exp Allergy, 46, pp.411~421 (2016)
  6. Bich Tra Cao Thi, "Serum Amyloid A1: A Biomarker for Neutrophilic Airway Inflammation in Adult Asthmatic Patients", Allergy, Asthma & Immunology Research, 14(1), pp.40~58 (2022), 대한천식알레르기학회[DOI]
  7. Agusti A, "Treatable traits : toward precision medicine of chronic airway diseases", Eur Respir J, 47, pp.410~419 (2016)
  8. 송우정, "Future Risks in Patients With Severe Asthma", Allergy, Asthma & Immunology Research, 11(6), pp.763~778 (2019), 대한천식알레르기학회
  9. "2023 GINA main report:global strategy for asthma management and prevention" (2023)[URL]
  10. Juniper EF, "Development and validation of a questionnaire to measure asthma control", Eur Respir J, 14, pp.902~907 (1999)
  11. Nathan RA, "Development of the asthma control test : a survey for assessing asthma control", J Allergy Clin Immunol, 113, pp.59~65 (2004)
  12. Diver S, "Cough and eosinophilia", J Allergy Clin Immunol Pract, 7, pp.1740~1747 (2019)
  13. Johnson MJ, "Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness", Eur Respir J, 49, pp.1602277~ (2017)
  14. Chung KF, "Cough hypersensitivity and chronic cough", Nat Rev Dis Primers, 8, pp.45~ (2022)
  15. Çolak Y, "Role and impact of chronic cough in individuals with asthma from the general population", J Allergy Clin Immunol Pract, 7, pp.1783~1792 (2019)
  16. Deng SJ, "Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes", Allergy Asthma Proc, 43, pp.209~219 (2022)
  17. Lai K, "Cough and cough hypersensitivity as treatable traits of asthma", Lancet Respir Med, 11, pp.650~662 (2023)
  18. Mincheva R, "Frequent cough in unsatisfactory controlled asthma--results from the population-based West Sweden Asthma study", Respir Res, 15, pp.79~ (2014)
  19. Marsden PA, "Objective cough frequency, airway inflammation, and disease control in asthma", Chest, 149, pp.1460~1466 (2016)
  20. Holmes J, "An observational study to determine the relationship between cough frequency and markers of inflammation in severe asthma", Eur Respir J, 60, pp.2103205~ (2022)
  21. Song WJ, "Patients' experiences of asthma exacerbation and management : a qualitative study of severe asthma", ERJ Open Res, 7, pp.00528~2020 (2021)
  22. Holmes J, "Adverse perception of cough in patients with severe asthma : a discrete choice experiment", ERJ Open Res, 9, pp.00442~2022 (2023)
  23. de Marco R, "Prognostic factors of asthma severity : a 9-year international prospective cohort study", J Allergy Clin Immunol, 117, pp.1249~1256 (2006)
  24. Cho PSP, "Methods of cough assessment", J Allergy Clin Immunol Pract, 7, pp.1715~1723 (2019)
  25. Rhatigan K, "Patient global impression of severity scale in chronic cough : validation and formulation of symptom severity categories", J Allergy Clin Immunol Pract (2023)[DOI]
  26. 권재우, "Reliability and Validity of a Korean Version of the Leicester Cough Questionnaire", Allergy, Asthma & Immunology Research, 7(3), pp.230~233 (2015), 대한천식알레르기학회
  27. Vertigan AE, "Feasibility and clinical utility of ambulatory cough monitoring in an outpatient clinical setting : a real-world retrospective evaluation", ERJ Open Res, 7, pp.00319~2021 (2021)
  28. Lee SE, "Feasibility and utility of a smartphone application-based longitudinal cough monitoring in chronic cough patients in a real-world setting", Lung, 201, pp.555~564 (2023)
  29. Satia I, "Capsaicin-evoked cough responses in asthmatic patients : evidence for airway neuronal dysfunction", J Allergy Clin Immunol, 139, pp.771~779 (2017)
  30. Belvisi MG, "Neurophenotypes in airway diseases. insights from translational cough studies", Am J Respir Crit Care Med, 193, pp.1364~1372 (2016)
  31. Purokivi M, "Determinants of asthma control and quality of life in stable asthma : evaluation of two new cough provocation tests", Clin Respir J, 7, pp.253~260 (2013)
  32. Wang R, "Investigating the safety of capsaicin cough challenge in severe asthma", Clin Exp Allergy, 49, pp.932~934 (2019)
  33. McGarvey LP, "Increased expression of bronchial epithelial transient receptor potential vanilloid 1 channels in patients with severe asthma", J Allergy Clin Immunol, 133, pp.704~712 (2014)
  34. 원하경, "Cough-Related Laryngeal Sensations and Triggers in Adults With Chronic Cough: Symptom Profile and Impact", Allergy, Asthma & Immunology Research, 11(5), pp.622~631 (2019), 대한천식알레르기학회
  35. Lee JH, "Prevalence and impact of comorbid laryngeal dysfunction in asthma : a systematic review and meta-analysis", J Allergy Clin Immunol, 145, pp.1165~1173 (2020)
  36. Vertigan AE, "Laryngeal dysfunction in severe asthma : a cross-sectional observational study", J Allergy Clin Immunol Pract, 9, pp.897~905 (2021)
  37. 강유리, "후두 기능이상: 정의와 진단법", Allergy Asthma & Respiratory Disease, 12(2), pp.48~57 (2024), 대한 소아알레르기 호흡기학회[DOI]
  38. Satia I, "Allergen challenge increases capsaicin-evoked cough responses in patients with allergic asthma", J Allergy Clin Immunol, 144, pp.788~795 (2019)
  39. Satia I, "The interaction between bronchoconstriction and cough in asthma", Thorax, 72, pp.1144~1146 (2017)
  40. Kahrilas PJ, "Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease", Chest, 143, pp.605~612 (2013)
  41. Lee JH, "Effects of bepotastine, a nonsedating H1-antihistamine, for the treatment of persistent cough and allergic rhinitis : a randomised, double-blind, placebo-controlled trial", ERJ Open Res, 9, pp.00448~ (2023)
  42. Haldar P, "Mepolizumab and exacerbations of refractory eosinophilic asthma", N Engl J Med, 360, pp.973~984 (2009)
  43. Ito K, "Targeting the interleukin-5 pathway improves cough hypersensitivity in patients with severe uncontrolled asthma", Ann Allergy Asthma Immunol, 131, pp.203~208 (2023)
  44. Kanemitsu Y, "Increased capsaicin sensitivity in patients with severe asthma is associated with worse clinical outcome", Am J Respir Crit Care Med, 201, pp.1068~1077 (2020)
  45. Mitchell SAFC, "Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough : a multicentre randomised control trial", Thorax, 72, pp.129~136 (2017)
  46. 송우정, "만성 기침의 새로운 임상 접근법: 최근 진료 지침을 기반으로", 대한내과학회지, 94(6), pp.471~484 (2019), 대한내과학회[DOI]
  47. McGarvey LP, "Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough(COUGH-1 and COUGH-2) : results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3trials", Lancet, 399, pp.909~923 (2022)
  48. Basoglu OK, "Effects of aerosolized adenosine 5'-triphosphate vs adenosine 5'-monophosphate on dyspnea and airway caliber in healthy nonsmokers and patients with asthma", Chest, 128, pp.1905~1909 (2005)
  49. Pellegrino R, "Lung mechanics during induced bronchoconstriction", J Appl Physiol(1985), 81, pp.964~975 (1996)
  50. Idzko M, "Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells", Nat Med, 13, pp.913~919 (2007)
  51. Holmes J, "Objective and subjective measurement of cough in asthma : a systematic review of the literature", Lung, 200, pp.169~178 (2022)

관련 논문AI추천

이 간행물의 다른 논문 (7건)